Who Paid My Doc
Cerenovus Enterprise
Device Neurovascular
PDI 10886704075394
General payments
$55,158
Research payments
$0
Through program year 2025, $55,158 in general payments and $0 in research payments were reported against Cerenovus Enterprise (Neurovascular).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $4,870 | 48 |
| 2024 | General | $17,004 | 151 |
| 2023 | General | $416 | 8 |
| 2022 | General | $12,255 | 50 |
| 2021 | General | $20,613 | 47 |
Breakdown
The top 5 of 25 recipients; each share is of general payments naming this product in 2025.
The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 10 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
304 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.